TY - JOUR
T1 - EU pancreas
T2 - An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease
AU - the COST Action BM1204 participants
AU - Milne, Roger
AU - La Vecchia, C.
AU - Van Steen, K.
AU - Hahn, S.
AU - Buchholz, M.
AU - Costello, E.
AU - Esposito, I.
AU - Hoheisel, J. D.
AU - Lange, B.
AU - Lopez-Bigas, N.
AU - Michalski, C. W.
AU - Real, F. X.
AU - Brand, A.
AU - Malats, N.
AU - Van Steen, Kristel
AU - Macic, Drazenka
AU - Ceric, Timur
AU - Iovanna, Juan
AU - Hahn, Stephan
AU - Kleeff, Jorg
AU - Gazouli, Maria
AU - Dervenis, Christos
AU - Hegyi, Peter
AU - Ruhl, Ralph
AU - Shafat, Amir
AU - Sharp, Linda
AU - Rayan, Anwar
AU - DeCarli, Adriano
AU - Tortora, Giampolo
AU - Sileikis, Audrius
AU - Barauskas, Giedrius
AU - Eriksson Steigen, Sonja
AU - Ikdahl, Tone
AU - Malecka-Panas, Ewa
AU - Silva, Filipe Santos
AU - Barbu, Traian Sorin
AU - Popescu, Irinel
AU - Durisova, Maria
AU - Majekova, Magdalena
AU - Dolzan, Vita
AU - Genc, Lutfi
AU - Yildirim, Hatice
AU - Crnogorac-Jurcevic, Tajana
AU - Brand, Angela
AU - Costello, Eithne
AU - Bulchholz, Malte
AU - Greenhalf, Bill
AU - Campbell, Fiona
AU - Kloeppel, Gunter
AU - De Mesquita, Bas Bueno
AU - Brazma, Alvis
AU - Herwig, Raph
AU - Van Cutsum, Eric
AU - Goldstein, Darlene
AU - Birney, Ewan
AU - Bassi, Claudio
AU - Biankin, Andrew
AU - Scarpa, Aldo
AU - Michalski, Christoph
AU - Dufresne, Marlène
AU - Chelala, Claude
AU - Kocher, Hermant
AU - Steyerberg, Ewout
AU - Cecconi, Daniela
AU - Löhr, Matthias
AU - Gutierrez- Ibarluzea, Inaki
AU - Adany, Roza
AU - Horgan, Denis
AU - Taruscio, Domenica
AU - Wolff-Boehnisch, Bonnie
AU - Dauben, Hans Peter
AU - Barbardorttir, Rósa Björk
AU - Papadopoulos, Ilias
AU - Callens, Philippe
AU - Holcatova, Ivana
AU - Brenner, Hermann
AU - Campa, Daniele
AU - Canzian, Federico
AU - Rizzato, Cosmeri
AU - Lüttges, Jutta
AU - Gress, Thomas
AU - Bartch, Detlef
AU - Vlahou, Tonia
AU - Fillat, Cristina
AU - Bayés, Mònica
AU - Gut, Ivo
AU - Gut, Marta
AU - Gasull, Magda
AU - Barberá, Víctor
AU - Porta, Miquel
AU - Molero, Xavier
AU - Duell, Eric
AU - Ález-Couto, Eduardo
AU - Carrato, Alfredo
AU - Guillén, Carmen
AU - Martinelli, Paola
AU - Hidalgo, Manuel
AU - Heeschen, Christopher
AU - Valencia, Alfonso
AU - Calle, Ma Luz
N1 - Publisher Copyright:
© 2013 S. Karger AG, Basel.
PY - 2013/4/20
Y1 - 2013/4/20
N2 - Background: Large-scale international collaboration is essential to decipher relevant information in the context of omics-scale interrogations in cancer research. This is even more important for rare and fatal diseases like pancreas cancer (PC). Methods: The COST Action BM1204 is a unique platform to facilitate the collaboration of a broad range of European and international PC multidisciplinary research groups in order to: (1) integrate knowledge and experience in a multidisciplinary way 'from cell to society', (2) promote the application of uniform study tools and protocols, (3) foster their optimal use by early-stage researchers, (4) enhance the mobility and training of researchers, and (5) disseminate the results produced to the broader society. Results: This Action will develop novel interdisciplinary tools for collaborative research to improve our understanding of PC and its prevention, diagnosis and treatment. It also aims to answer questions related to the etiology, early detection, evidence-based and personalized treatment, and health management for PC. Furthermore, the Action will contribute to new insights into PC personalized medicine and beyond as well as to the understanding of complex and rare diseases taking PC as a best practice example. The Action aims at attracting young scholars across a range of disciplines in collaboration with more experienced researchers and enhancing active European participation in the international scenario of PC research. Conclusion: The ultimate aim is to foster PC research in Europe and to coordinate this effort with other international initiatives to reduce disease mortality.
AB - Background: Large-scale international collaboration is essential to decipher relevant information in the context of omics-scale interrogations in cancer research. This is even more important for rare and fatal diseases like pancreas cancer (PC). Methods: The COST Action BM1204 is a unique platform to facilitate the collaboration of a broad range of European and international PC multidisciplinary research groups in order to: (1) integrate knowledge and experience in a multidisciplinary way 'from cell to society', (2) promote the application of uniform study tools and protocols, (3) foster their optimal use by early-stage researchers, (4) enhance the mobility and training of researchers, and (5) disseminate the results produced to the broader society. Results: This Action will develop novel interdisciplinary tools for collaborative research to improve our understanding of PC and its prevention, diagnosis and treatment. It also aims to answer questions related to the etiology, early detection, evidence-based and personalized treatment, and health management for PC. Furthermore, the Action will contribute to new insights into PC personalized medicine and beyond as well as to the understanding of complex and rare diseases taking PC as a best practice example. The Action aims at attracting young scholars across a range of disciplines in collaboration with more experienced researchers and enhancing active European participation in the international scenario of PC research. Conclusion: The ultimate aim is to foster PC research in Europe and to coordinate this effort with other international initiatives to reduce disease mortality.
KW - COST Action BM1204
KW - Data integration
KW - Early-stage researchers
KW - Harmonization
KW - Omics data
KW - Pancreas cancer
KW - Public health
KW - Rare disease
KW - Training and mobility
UR - http://www.scopus.com/inward/record.url?scp=84899918007&partnerID=8YFLogxK
U2 - 10.1159/000355937
DO - 10.1159/000355937
M3 - Article
C2 - 24503591
AN - SCOPUS:84899918007
SN - 1662-4246
VL - 16
SP - 305
EP - 312
JO - Public Health Genomics
JF - Public Health Genomics
IS - 6
ER -